Greenwich LifeSciences In... (GLSI)
NASDAQ: GLSI
· Real-Time Price · USD
10.19
-0.23 (-2.21%)
At close: Sep 26, 2025, 11:08 AM
-2.21% (1D)
| Bid | 9.83 |
| Market Cap | 138.89M |
| Revenue (ttm) | 3.61K |
| Net Income (ttm) | -17.99M |
| EPS (ttm) | -1.37 |
| PE Ratio (ttm) | -7.44 |
| Forward PE | -7.4 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 9.97 |
| Volume | 61,834 |
| Avg. Volume (20D) | 68,987 |
| Open | 10.21 |
| Previous Close | 10.42 |
| Day's Range | 9.76 - 10.29 |
| 52-Week Range | 8.06 - 15.47 |
| Beta | 3.16 |
| Ex-Dividend Date | n/a |
About GLSI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GLSI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GLSI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+3.55%
Greenwich LifeSciences shares are trading higher a...
Unlock content with
Pro Subscription
5 months ago
+0.97%
Greenwich LifeSciences shares are trading higher after the company announced immune response data from its FLAMINGO-01 Phase 3 clinical trial.
